SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193280.
  • 2
    Branch D, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Dayanes RA. Immunoglobulin G fraction from patients with antiphospholipid antibodies caused fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 63: 2106.
  • 3
    Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991; 88: 306973.
  • 4
    Piona A, La Rosa L, Tincani A, Faden D, Magro G, Grasso S, et al. Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/C mice. Scand J Immunol 1995; 41: 42732.
  • 5
    Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other phospholipid antibodies. Blood 1994; 89: 285467.
  • 6
    Viard JP, Amoura Z, Bach JF. Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 1816.
  • 7
    Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M. Detection of β-2-glycoprotein-I-dependent antiphospholipid antibodies and anti-beta-2-glycoprotein-I antibody in patients with systemic lupus erythematosus and in patients with syphilis. Int Arch Allergy Immunol 1994; 103: 23944.
  • 8
    El-Kadi HS, Keil LB, DeBari VA. Analytical and clinical relationships between human IgG autoantibodies to β2 glycoprotein I and anticardiolipin antibodies. J Rheumatol 1995; 22: 22337.
  • 9
    Kaburaki J, Kuwana M, Yamamoto M, Matsuura E, Ikeda Y. Clinical significance of phospholipid-dependent anti-β2 glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus. Lupus 1995; 4: 4726.
  • 10
    Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, et al. Anti-β2 glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 12230.
  • 11
    McNally T, Mackie IJ, Machin SJ, Isenberg DA. Increased levels of β2 glycoprotein-I antigen and beta 2 glycoprotein-I antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Haematol 1995; 34: 10316.
  • 12
    Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β-2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899906.
  • 13
    Martinuzzo ME, Forastiero RR, Carreras LO. Anti β2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397402.
  • 14
    Koike T, Matsuura E. Anti-β2-glycoprotein I antibody: specificity and clinical significance. Lupus 1996; 5: 37880.
  • 15
    Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GR. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1997; 35: 123943.
  • 16
    Sanmarco M, Soler C, Christides C, Raoult D, Weiller PJ, Gerolami V, et al. Prevalence and clinical significance of IgG isotype anti-β2 glycoprotein I antibodies on antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J Lab Clin Med 1997; 129: 499506.
  • 17
    Teixido M, Font J, Reverter JC, Cervera R, Tassies D, Ingelmo M, et al. Anti-β2 glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome. Br J Rheumatol 1997; 36: 1136.
  • 18
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, et al. Anticardiolipin, anti-β(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24: 17105.
  • 19
    Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997; 89: 97580.
  • 20
    La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, et al. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-β2-glycoprotein I antibodies. Clin Exp Immunol 1998; 112: 14451.
  • 21
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998; 25: 66774.
  • 22
    Cucurull E, Espinoza LR, Mendez E, Molina JF, Molina J, Ordi-Ros J, et al. Anticardiolipin and anti-β2glycoprotein I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards. Lupus 1999; 8: 13441.
  • 23
    McIntyre JA. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992; 28: 12731.
  • 24
    La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden D, Lojacono A, et al. β2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994; 21: 168493.
  • 25
    George J, Blank M, Levy Y, Meroni PL, Damianovich M, Tincani A, et al. Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97: 9006.
  • 26
    Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B, et al. Immunization with anticardiolipin cofactor (β-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 44155.
  • 27
    Ikematsu W, Luan F-L, La Rosa L, Beltrami B, Nicoletti F, Buyon JP, et al. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum 1998; 41: 102639.
  • 28
    Vogt E, Ng AK, Rote NS. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996; 174: 7007.
  • 29
    Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 17986.
  • 30
    Salafia CM, Starzyk K, Lopez-Zeno J, Parke A. Fetal losses and other obstetrical manifestations in the antiphospholipid syndrome. In: AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome. Boca Raton (FL): CRC Press; 1996. p. 11731.
  • 31
    Rote NS, Vogt E, DeVere G, Obringer AR, Ng AK. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1998; 39: 12536.
  • 32
    Di Simone N, De Carolis S, Lanzone A, Ronsisvalle E, Giannice R, Caruso A. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotropin releasing hormone-dependent human chorionic gonadotropin release by cultured trophoblast cells. Placenta 1995; 16: 7583.
  • 33
    Rand JH, Wu X, Andree HAM, Lockwood CJ, Guller S, Scher J, et al. Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 1997; 337: 15460.
  • 34
    Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 4828.
  • 35
    Tincani A, Spatola L, Prati E, Allegri F, Ferremi P, Cattaneo R, et al. The anti-β2-glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species evolution. J Immunol 1996; 157: 57328.
  • 36
    Harris EN. The second international anti-cardiolipin standardization workshop: the Kingston Anti-Phospholipid Antibody Study Group. Am J Clin Pathol 1990; 94: 47684.
  • 37
    Allegri F, Balestrieri G, Cattaneo R, Martinelli M, Tincani A, Barcellini W, et al. The plasma cofactor and anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 6135.
  • 38
    Poltz E, Wurm H, Kostner GM. Investigation on β2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fraction. J Biochem 1994; 21: 168493.
  • 39
    Exner T, Richard KA, Kronenberg HA. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 14351.
  • 40
    Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499509.
  • 41
    Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 118590.
  • 42
    Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV. β2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994; 37: 145361.
  • 43
    Roubey RAS, Eisenberg RA, Harper MF, Winfield JB. “Anticardiolipin” autoantibodies recognize β2-glycoprotein I in the absence of phospholipid: importance of antigen density and bivalent binding. J Immunol 1995; 154: 95460.
  • 44
    Del Papa N, Sheng YH, Raschi E, Kandiah DA, Tincani A, Khamashta MA, et al. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J Immunol 1998; 160: 55728.
  • 45
    Dietzschold B, Gore M, Casali P, Ueki Y, Rupprecht CE, Notkins AL, et al. Biological characterization of human monoclonal antibodies to rabies virus. J Virol 1990; 64: 308790.
  • 46
    Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118: 156782.
  • 47
    Ferraro G, Meroni PL, Del Papa N, Barcellini W, Borghi MO, Lazzarin A, et al. In vitro modulation of human endothelial cell growth by Kaposi's sarcoma sera. J AIDS 1990; 3: 67782.
  • 48
    Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK. Resistance of malignant trophoblast cells to both the antiproliferative and antiinvasive effects of transforming growth factor-β. Exp Cell Res 1994; 214: 939.
  • 49
    Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies: human polyclonal and monoclonal anti–β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 55161.
  • 50
    Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39: 144454.
  • 51
    Lakasing L, Poston L. Adverse pregnancy outcome in the antiphospholipid syndrome: focus for future research. Lupus 1997; 6: 6814.
  • 52
    Chamley LM, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 10378.